Real-time enrollment status for this carcinoid syndrome clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 12:12 AM UTC
| NCT Number | NCT07087054 |
| Recruiting Status | Recruiting |
| Condition | Carcinoid Syndrome |
| Phase | PHASE3 |
| Target Enrollment | 141 participants |
| Active Locations | 17 sites in the US |
| Sponsor | Crinetics Pharmaceuticals Inc. |
| Last Updated on CT.gov | June 25, 2026 (3 weeks ago) |
As of July 19, 2026: Clinical trial NCT07087054 is currently recruiting participants. This phase3 study for carcinoid syndrome is actively seeking new participants at 17 locations across the United States. The study is sponsored by Crinetics Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07087054 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07087054 was last updated 3 weeks ago (June 25, 2026). HelloStudys verifies this status automatically.